WallStSmart

BlackRock Inc (BLK)vsBlackRock Science and Technology Trust II (BSTZ)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BLK leads profitability with a 24.4% profit margin vs 0.0%. BSTZ trades at a lower P/E of 6.6x. BLK earns a higher WallStSmart Score of 78/100 (B+).

BLK

Strong Buy

78

out of 100

Grade: B+

Growth: 8.7Profit: 7.5Value: 5.7Quality: 7.0
Piotroski: 2/9Altman Z: 1.13

BSTZ

Avoid

33

out of 100

Grade: F

Growth: 4.3Profit: 5.5Value: 6.7Quality: 6.3
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BLK6 strengths · Avg: 8.8/10
Operating MarginProfitability
35.6%10/10

Strong operational efficiency at 35.6%

Market CapQuality
$158.18B9/10

Large-cap with strong market position

Profit MarginProfitability
24.4%9/10

Keeps 24 of every $100 in revenue as profit

Debt/EquityHealth
0.269/10

Conservative balance sheet, low leverage

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
27.0%8/10

Revenue surging 27.0% year-over-year

BSTZ3 strengths · Avg: 10.0/10
P/E RatioValuation
6.6x10/10

Attractively priced relative to earnings

Return on EquityProfitability
34.2%10/10

Every $100 of equity generates 34 in profit

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Areas to Watch

BLK4 concerns · Avg: 2.8/10
P/E RatioValuation
25.6x4/10

Moderate valuation

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Free Cash FlowQuality
$-1.19B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
1.132/10

Distress zone — elevated risk

BSTZ4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : BLK

The strongest argument for BLK centers on Operating Margin, Market Cap, Profit Margin. Profitability is solid with margins at 24.4% and operating margin at 35.6%. Revenue growth of 27.0% demonstrates continued momentum.

Bull Case : BSTZ

The strongest argument for BSTZ centers on P/E Ratio, Return on Equity, Debt/Equity.

Bear Case : BLK

The primary concerns for BLK are P/E Ratio, Piotroski F-Score, Free Cash Flow.

Bear Case : BSTZ

The primary concerns for BSTZ are Revenue Growth, EPS Growth, Profit Margin.

Key Dynamics to Monitor

BLK profiles as a growth stock while BSTZ is a value play — different risk/reward profiles.

BLK is growing revenue faster at 27.0% — sustainability is the question.

BSTZ generates stronger free cash flow (-33M), providing more financial flexibility.

Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BLK scores higher overall (78/100 vs 33/100), backed by strong 24.4% margins and 27.0% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BlackRock Inc

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

BlackRock, Inc. is an American multinational investment management corporation based in New York City.

BlackRock Science and Technology Trust II

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

BlackRock Science and Technology Trust II (BSTZ) is a closed-end fund managed by BlackRock that focuses on high-growth investment opportunities within the science and technology sectors. By targeting innovative companies at the forefront of technological advancements and scientific research, BSTZ seeks to capitalize on the substantial growth potential inherent in these dynamic fields. Leveraging BlackRock's extensive industry expertise, the fund aims to provide institutional investors with attractive total returns through a well-balanced approach that includes both capital appreciation and income generation. This investment vehicle offers a strategic avenue for portfolio diversification while capturing enduring trends in technology and healthcare innovation.

Want to dig deeper into these stocks?